TCAM1P is a unitary pseudogene, which was disabled since the human-mouse divergence. Here we found that TCAM1P was specifically expressed in the human testis, with different cell type-specificity from mouse Tcam1, and characterized its transcripts. At the mouse locus, a multifunctional dual promoter-enhancer (DPE) controls the expression of Tcam1 and Smarcd2 genes. This time, the corresponding human sequence was found to potentially function as a DPE, although the molecular mechanism was different from mouse. Interestingly, the change in DPE activity occurred before pseudogenization of TCAM1P. These data suggest the presence of a DPE in human genome for the first time, and provide an important model of evolutionary changes in a regulatory mechanism of a pseudogene.
Introduction
Functions and expression patterns of orthologous genes are generally conserved between closely related species [1, 2] , but it is not the case for pseudogenes. Pseudogenes have lost their original functions in the process of evolution, and are silenced or expressed as noncoding RNAs, sometimes with different patterns from their ancestral genes [3] . Recently, some of the transcribed pseudogenes were revealed to be functional and have novel roles [4] [5] [6] . Thus, it is of great importance to have a better understanding of pseudogenes, but many issues remain to be resolved. Especially, regulatory mechanisms of pseudogenes are largely unknown.
We previously investigated a regulatory mechanism at the mouse testicular cell adhesion molecule 1 (Tcam1) gene locus, and identified mouse conserved noncoding sequence 1 (mCNS1) as a multifunctional dual promoter-enhancer (DPE) [7] . mCNS1 could function as a spermatocyte-specific enhancer for Tcam1 and a bidirectional promoter of the SWI/SNF-related, matrix-associated, actin-dependent regulator of chromatin, subfamily d, member 2 (Smarcd2) gene and a testis-specific long noncoding RNA (lncRNA), lncRNA-Tcam1 [7] . This was the first indication of a DPE in mammals, although two examples had been reported in chicken [8, 9] .
Interestingly, while the synteny of Smarcd2 and Tcam1 genes is conserved among eutherians, a human orthologue of Tcam1, TCAM1P, is considered to be a pseudogene [10] , albeit mouse Tcam1 encodes a cell adhesion protein [11] . TCAM1P was pseudogenized since the human-mouse divergence [10] , and therefore, it is of significance to note whether expression patterns and regulatory mechanisms at the human TCAM1P locus are conserved or not. The mechanisms are also notable in terms of the gene regulation by multifunctional genomic elements, because the TCAM1P gene is linked to the human growth hormone (hGH) gene cluster, a famous model for tissue-specific gene activation by multifunctional elements [12] [13] [14] [15] [16] .
In this study, we investigated the expression and regulation of human TCAM1P and SMARCD2 genes. Our results indicated that the expression pattern of TCAM1P was slightly different from mouse Tcam1, and that human CNS1 (hCNS1) could function as a DPE, although the molecular mechanism was different from mCNS1. The data provide the first evidence for the presence of DPE in human genome, and represent an important model for gene regulatory mechanisms before and after pseudogenization.
Materials and methods

RNA Analyses
Total RNAs from the human liver and testis were purchased from Clontech Laboratories, Inc.
(Mountain View, USA) and reverse transcription-polymerase chain reaction (RT-PCR) was done as previously described [17] . Primer sequences are shown in Table 1 . The primer pair for β-ACTIN was used by another group [18].
Rapid amplification of cDNA ends (RACE)
5'RACE and 3'RACE were performed as previously described [7, 17] . All the amplified products were subcloned into a pBluescript vector (Stratagene, La Jolla, CA) by the TA-cloning method, and at least 10 subclones were sequenced for each product. All the primer sequences used for these analyses are listed in Table 1 .
Reporter constructs
A promoter region of the TCAM1P gene was amplified by PCR using KOD FX (Toyobo, Osaka, Japan) with human sperm genomic DNA (Clontech Laboratories, Inc.) and a primer pair listed in Table 1 . The 2012-bp product was ligated to upstream of the luciferase gene in a pGL3-Basic vector (Promega Corporation, Madison, WI) at the SmaI site, and we named the resulting construct TCAM1P-Pro-luc. To obtain the hCNS1 sequence, we had to perform two rounds of PCR reactions, presumably due to the high GC content of the region encompassing hCNS1. The first round PCR was performed by KOD FX (Toyobo) with human genomic DNA using the 'hCNS1 first' primer pair (Table 1) , and the 1340-bp product was purified and used as a template for the second PCR with the 'hCNS1 nested' primer pair (Table 1) . By inserting the 450-bp product into the blunted NheI site of TCAM1P-Pro-luc, we obtained the hCNS1-Pro-luc construct. To generate the Pro-luc-hCNS1 and Pro-luc-reversed (rev) hCNS1 constructs, we cloned the hCNS1 fragment into the blunted BamHI site of TCAM1P-Pro-luc. To linearize the constructs, we digested them by SalI. The hCNS1-luc and rev hCNS1-luc constructs were generated by inserting the hCNS1 sequence into the SmaI site of a pGL3-Basic vector. All the constructs were subject to the sequencing analysis prior to transfection studies.
Cell culture and the reporter gene assay
GC-2spd(ts), Hepa1-6, and HEK293T cells were cultured in Dulbecco's modified Eagle's medium containing 10% fetal bovine serum, 100 U/ml penicillin, 100 µg/ml streptomycin, and 292 µg/ml L-glutamine (Invitrogen, Carlsbad, CA). The reporter gene assay was performed as previously described [19] .
Statistical analysis
The results were expressed as means ± S.D. One-way analysis of variance (ANOVA) followed by Tukey-Kramer's test was performed using Microsoft Excel statistical analysis functions (Microsoft Corp., Redmond, WA). P < 0.05 was considered statistically significant.
Results
Tissue distribution of human SMARCD2 and TCAM1P mRNAs
We first investigated the tissue-specificity of human SMARCD2 and TCAM1P genes by searching for the next generation sequencing data on Integrative Genomics Viewer (IGV) (http://www.broadinstitute.org/igv). Transcript signals at the TCAM1P gene were most abundantly present in the testis among eleven human tissues, while significant levels were observed at the SMARCD2 gene in all the tissues (Fig. 1A) . To know what types of cells expressed TCAM1P mRNA in the human testis, we referred to microarray data of fractionated testicular germ cells and of the whole testis from patients whose spermatogenesis was arrested at various stages. Both data showed that TCAM1P mRNA was exclusively expressed in germ cells, mainly in spermatocytes, but weak signals were also detected in spermatogonia and spermatids [20, 21] . These indicated that the cell type-specificity of human TCAM1P was different from mouse Tcam1 which was expressed only in spermatocytes [7, 11] .
Because the TCAM1P gene was considered to be a pseudogene, we next investigated what kinds of transcripts were actually transcribed. According to the Ensembl database (http://www.ensembl.org/index.html), seven transcripts were transcribed from the TCAM1P gene as shown in Fig. 1B . To distinguish these transcripts, we designed four primer sets (Fig. 1B, P1-P4 ) and performed RT-PCR with human testis and liver RNAs. As a result, we could not amplify any specific products with P1, P2, and P4 in either tissue, but detected three specific bands in the testis with P3 (data not shown, Fig. 1C ). We named the detected transcripts, TCAM1P-I, TCAM1P-II, and (Fig. 1B, C) .
TCAM1P-III
Determination of full-length sequences of TCAM1P transcripts
To determine full-length sequences of the three TCAM1P transcripts, we conducted 5'RACE and 3'RACE analyses using the human testis RNA. 5'RACE was performed with two primer sets: one for detecting the transcriptional start site (TSS) of TCAM1P-I and TCAM1P-III (Fig. 2B) , and the other for TSS of TCAM1P-I and TCAM1P-II (Fig. 2C) . We identified one nucleotide at the position +401, which was 401 bp downstream of TSS in the Ensembl database ( Fig. 2A, B) , as TSS of TCAM1P-I and TCAM1P-III (Fig. 2B) . In contrast, we found five different TSSs of TCAM1P-I and TCAM1P-II, each of which was positioned at +494, +401, +377, +329, and +5100 (Fig. 2C) . The nucleotide at +401 might be derived from TCAM1P-I. These results indicated that there was one TSS of TCAM1P-I and TCAM1P-III at +401, and TCAM1P-II had at least four TSSs.
3'RACE was performed using a primer set that could detect the transcriptional termination site (TTS) of all the transcripts. Two TTSs were identified at the position of +10555 and +10837 (Fig. 2D ).
Because 8 out of 10 subclones contained the nucleotide at +10837 as TTS, it was considered to be a major TTS. To see whether all the three transcripts were actually terminated at the major TTS, we conducted RT-PCR by using a primer at the final exon for reverse transcription and a primer pair specific to each transcript for PCR. As a result, a specific signal was observed for each of the three transcripts (data not shown), which indicated that all the TCAM1P transcripts contained +10837 as their TTSs. We also examined whether the three transcripts were terminated at the minor TTS, but we could not detect any specific signals (data not shown).
Taken together, TCAM1P-II had at least four TSSs and one TTS, and TCAM1P-I and TCAM1P-III had one TSS and one TTS. Therefore, we concluded that at least six TCAM1P transcripts were present in the human testis as shown in Fig. 2E , and that the TCAM1P gene was actually composed of five exons ( Fig. 2A) .
Although the Tcam1 gene in rodents and rhesus monkey encodes a protein related to a cell adhesion molecule, the human TCAM1P gene is considered to be a pseudogene [10] . Since we determined full-length sequences of six TCAM1P transcripts, we searched for their open reading frames (ORFs). The maximum ORFs predicted from the nucleotide sequences were 99, 58, and 49 amino acids for TCAM1P-I, TCAM1P-II, and TCAM1P-III, respectively. However, amino acid sequences of those ORFs showed no homology to the mouse TCAM1 protein. Therefore, the human TCAM1P gene could be noncoding RNAs or could encode polypeptides that were not related to the TCAM1 protein of other species.
Enhancer and promoter activity of hCNS1
We then investigated a regulatory mechanism at the human SMARCD2-TCAM1P locus by examining whether hCNS1 could function as a DPE similarly to mCNS1.
We first investigated enhancer activity of hCNS1. Because TSS of TCAM1P-I and TCAM1P-III was +401 and three TSSs of TCAM1P-II were close to +401 (Fig. 2E) , we cloned about 2-kb sequence upstream of +401 as a major promoter of the TCAM1P gene and connected it to the luciferase gene (TCAM1P-Pro-luc). hCNS1 was amplified by genome PCR and cloned to upstream of the TCAM1P promoter (hCNS1-Pro-luc) or to downstream of the luciferase gene (Pro-luc-hCNS1 and Pro-luc-rev hCNS1). Enhancer activity of hCNS1 was assessed by reporter gene assay with three cell lines, GC2-spd(ts), Hepa1-6, and HEK293T, which were derived from mouse spermatocytes, mouse hepatocytes, and human embryonic kidney, respectively.
The activity of hCNS1-Pro-luc was significantly increased in all three cell lines compared to the construct without hCNS1 (Fig. 3A) . When we connected hCNS1 to 3'of the luciferase gene, the activity was also significantly increased in all cells irrespective of its orientation (Fig. 3A) .
Fold-increases were 1.8-3.5 in most experiments, but a 4.5-fold increase was observed in GC-2spd(ts) cells when hCNS1 was connected to 3' of the luciferase gene in forward orientation (Fig. 3A, Pro-luc-hCNS1). We do now know the reason for the variable activity, but there were several reports of enhancers showing different activity depending on its position or direction by reporter gene assay [22] [23] [24] [25] .
We also examined the luciferase activity in linearized constructs. If hCNS1 was actually a DPE, it might drive the transcription of the entire sequence in a circular plasmid, which might affect the luciferase gene expression. To prevent hCNS1 from driving the luciferase gene transcription in the sense direction, we linearized Pro-luc-hCNS1 and Pro-luc-rev hCNS1 constructs by cutting the immediate downstream sequence of hCNS1 and rev hCNS1. As a result, hCNS1 still significantly increased TCAM1P promoter activity in HEK293T cells, and the fold-increases were around 3 in both constructs compared to the linearized TCAM1P-Pro-luc construct (Fig. 3B ). These data showed that hCNS1 could function as an enhancer for the TCAM1P gene.
We next investigated whether hCNS1 had promoter activity or not. Since hCNS1 encompassed exon 1 and an upstream region of SMARCD2, it was regarded as a promoter of SMRACD2. To assess the promoter activity of hCNS1, we connected it directly to the luciferase gene in both orientations (Fig. 4) . By reporter gene assay, hCNS1 showed promoter activity in both directions, but the activity was stronger in the reverse direction in all the cell lines (Fig. 4) . This indicated that hCNS1 had bidirectional promoter activity, but the activity was stronger for the SMARCD2 gene.
Intergenic transcription at the human SMARCD2-TCAM1P locus
At the mouse Smarcd2-Tcam1 locus, mCNS1 can drive not only Smarcd2 but also lncRNA-Tcam1 [7] . Because hCNS1 showed bidirectional promoter activity by reporter gene assay (Fig. 4) , we assessed the possibility that hCNS1 could be a promoter for an lncRNA as well as SMARCD2. We performed RT-PCR with the human testis RNA and successfully amplified the hCNS2 sequence (data not shown) which was positioned close to hCNS1 (Fig. 5A) . To determine the full-length sequence of the transcript, we performed 5'RACE and 3'RACE analyses. By sequencing 10 subclones each for 5'RACE and 3'RACE, we detected a single TSS and a single TTS (data not shown). Consequently, we identified a 1.1-kb transcript including one intron ( Fig. 5A ) and named it lncRNA-TCAM1P, because it was classified as an lncRNA by the coding potential calculator [26] . However, the lncRNA-TCAM1P promoter region did not overlap with hCNS1 ( Fig. 5A ), which indicated that hCNS1 was not a promoter for lncRNA-TCAM1P.
We then investigated the possible presence of other transcripts from the intergenic region between SMARCD2 and TCAM1P genes. By RT-PCR with six primer pairs (Fig. 5A, 1-6 ) and human testis and liver RNAs, we detected specific signals from all the examined regions in the testis, but not in the liver (Fig. 5B ). This indicated that, consistent with Fig. 1A , most of the intergenic region between SMARCD2 and TCAM1P genes were specifically transcribed in the testis.
To further characterize the intergenic transcription, we attempted to determine full-length sequences of the transcripts from amplicons 1 and 2. However, because approximately 70% sequence from 3' end of amplicon 2 overlapped with repeat sequences, we performed 5'RACE only for this transcript, while both ends were determined for amplicon 1. As a result, we detected three TSSs and three TTSs for amplicon 1, and two TSSs for amplicon 2 (Fig. 5C, D) . Judging from the number of subclones, a major TSS was presumed to be the nucleotide at -6124 bp and -5339 bp relative to TSS of TCAM1P for ampicons 1 and 2, respectively, and a major TTS for amplicon 1 was positioned at -4563 bp (Fig. 5C, D) . Collectively, we identified two novel lncRNAs: a full-length sequence of lncTCAM1P-6.1kb (Fig. 5C ) and a partial sequence of lncTCAM1P-5.3kb (Fig. 5D ). These transcripts were confirmed to be transcribed as single transcripts by RT-PCR performed as described in section 3.2 (data not shown).
As pointed out by many researchers [27, 28] , it was difficult to directly align the human lncRNAs we detected with mouse lncRNA-Tcam1, but they might be functionally homologous. What is important is that promoters of lncTCAM1P-6.1kb and lncTCAM1P-5.3kb did not overlap with hCNS1, which indicated that hCNS1 could not be promoters of these lncRNAs. The data suggest that hCNS1 may be a unidirectional promoter, although we cannot completely rule out the possibility that it functions bidirectionally.
Changes of CNS1 activity before pseudogenization of TCAM1P
The above data revealed the functional difference between mCNS1 and hCNS1, and we finally investigated how CNS1 activity was changed during evolution. Zhang et al. demonstrated that TCAM1P was pseudogenized at the gorilla-chimpanzee divergence by comparing genomic sequences from several primate species [10] , and we examined the evolutionary change in CNS1. We collected CNS1 sequences from mouse, rat, an old world monkey (rhesus monkey), a great ape (gibbon), and human by searching for the Ensembl and NCBI (http://blast.ncbi.nlm.nih.gov/Blast.cgi) databases, and compared each sequence with another. As a result, hCNS1 shared more than 90% nucleotide identity with CNS1 of rhesus monkey and gibbon, in contrast to less than 80% with that of rodents (Fig. 6A) .
Conversely, mCNS1 showed 93% nucleotide identity with rat CNS1, but had less than 80% with other species (Fig. 6A ). In addition, we could not find any nucleotides in CNS1 that were changed only in human and conserved in the other four species to allow hCNS1 to possess a specific function to human (Fig. 6B) . Therefore, CNS1 is presumed to be functionally changed before pseudogenization of TCAM1P, which suggests that cell-type specificity of the TCAM1 gene was altered before the pseudogenization.
Discussion
hCNS1 is a potential DPE
One aim of this study was to determine whether human genome contained a DPE, and we assessed enhancer activity of hCNS1. Although all the constructs containing hCNS1 increased TCAM1P promoter activity (Fig. 3) , the strong promoter activity of hCNS1 might affect the luciferase gene expression. Even in the assay with linearized constructs, hCNS1 and rev hCNS1 might drive the transcription of the luciferase gene in the antisense direction, which might affect the luciferase expression. However, because the promoter activity of hCNS1 was orientation-dependent (Fig. 4) , the antisense transcription would affect the luciferase activity to different extents in the Pro-luc-hCNS1
and Pro-luc-rev hCNS1 constructs. Nonetheless, the activity in these constructs was similar (Fig. 3B) , which indicated that the antisense transcription was unlikely to affect the luciferase gene expression.
Therefore, we conclude that hCNS1 is a potential enhancer for TCAM1P similarly to mCNS1.
Interestingly, a mechanism underlying the enhancer activity seemed to be different, because hCNS1 enhancer activity was observed in all the cell lines we examined (Fig. 3) , whereas mCNS1 enhancer activity was specific to spermatocyte-derived GC-2spd(ts) cells [7] . This indicates that different transcription factors function in different nucleotides between mCNS1 and hCNS1. In the human testis, a transcription factor common to various cell types may bind to hCNS1 and up-regulate the TCAM1P expression. In this case, the testis-specific TCAM1P gene activation may be controlled by the epigenetic state or by other cis-/trans-elements.
hCNS1 also showed bidirectional promoter activity, but the activity was stronger for SMARCD2 than for the opposite direction (Fig. 4) . This is in contrast to mCNS1, whose promoter activity in each direction was similar [7] . Because we failed to detect any transcripts driven by hCNS1 extending to the opposite direction of SMARCD2 (Fig. 5) , hCNS1 may be a unidirectional promoter. However, hCNS1 promoter activity opposite to SMARCD2 was still much higher than that of TCAM1P promoter (Fig. 4) , and there were transcripts, other than the three lncRNAs we identified, transcribed from the intergenic region between SMARCD2 and TCAM1P genes (Fig. 1A, Fig. 5 ). Further analysis will be necessary to reveal whether hCNS1 is a bidirectional promoter or not, but our data clearly indicate that hCNS1 is at least a promoter of the SMARCD2 gene.
Taken together, hCNS1 could enhance TCAM1P promoter activity and functioned as a promoter of the SMARCD2 gene. Therefore, similarly to mCNS1, hCNS1 can be a DPE in the human testis.
Evolutionary changes in parallel with pseudogenization
Another aim of this work was to determine evolutionary changes, especially in gene regulatory mechanisms, in light of the pseudogenization of the human TCAM1P gene. Pseudogenes are generally classified as unitary, duplicated, and retrotransposed pseudogenes, which were generated by spontaneous mutations in a single copy gene, duplication of a genomic region, and retrotransposition of processed mRNAs into other genomic regions, respectively [29] . TCAM1P is a unitary pseudogene [10] , and it is possible to directly compare the human TCAM1P locus with the mouse one.
In both human and mouse, we confirmed ubiquitous Smarcd2/SMARCD2 expression and DPE activity of mCNS1/hCNS1, but otherwise, many differences were found by our analyses. Firstly, human TCAM1P was testis-specific, but the cell type expressing it was not only spermatocytes but also spermatogonia and spermatids, whereas mouse Tcam1 mRNA was specific to spermatocytes [7, 20, 21] . Secondly, functions of TCAM1P and Tcam1 are obviously different. TCAM1P does not encode a cell adhesion molecule, and instead, encodes smaller peptides or functions as lncRNAs.
Thirdly, hCNS1 showed enhancer activity in more cell types than mCNS1, indicating different molecular mechanisms between these two species as discussed above. Fourthly, hCNS1 enhancer activity was lower than mCNS1. By reporter gene assay, mCNS1 mostly showed about 5-fold higher activity than Tcam1 promoter [7] , while the activity of hCNS1 was 1.8-4.5-fold higher than TCAM1P promoter (Fig. 3) . Fifthly, hCNS1 may not be a bidirectional promoter as discussed above. Finally, more lncRNAs were transcribed at the human locus. These indicates that the expression of TCAM1P and lncRNAs was changed during evolution, and that the gene regulation at this locus, especially the molecular mechanism underlying DPE activity, was also changed.
Furthermore, we found that CNS1 activity was changed before pseudogenization of the TCAM1P gene. This suggests that the TCAM1 gene is expressed in spermatogonia, spermatocytes, and spermatids not only in human but also in rhesus monkey and gibbon that contain the protein-coding TCAM1 gene. If this is the case, the cell adhesion protein may be necessary in the three types of germ cells during meiosis in rhesus monkey and gibbon, but unnecessary in chimpanzee and human.
Considering that Tcam1-knockout mice were normal [11] and the function of TCAM1 as a cell adhesion molecule is probably redundant, the TCAM1P pseudogene might gain a new role in chimpanzee and human. In this context, it is of note that human TCAM1P, together with other testis-specific genes, was induced in human papillomavirus-positive cancer cells [30] . TCAM1P may have some functions related both to cell proliferation and to male meiosis.
In any case, the present data provide an important example of evolutionary changes, especially in gene regulatory mechanisms, in parallel with pseudogenization.
Regulation of the SMARCD2-TCAM1P-hGH locus by multifunctional genomic elements
Finally, it is interesting to note gene regulation by multifunctional genomic elements because the human TCAM1P gene is linked to the hGH gene cluster. The hGH cluster contains one pituitary-specific and four placenta-specific paralogues [31,32], and their tissue-specific expression is related to some multifunctional elements. Firstly, the hGH cluster is controlled by the locus control region (LCR), which overlapps with the SCN4A gene encoding a sodium channel protein in the skeletal muscle [12, 33, 34] . Secondly, the hGH LCR activates the cluster genes by different mechanisms between pituitaty and placenta [16, [35] [36] [37] [38] . Thirdly, the CD79b gene, which is located between the LCR and the cluster, functions as a noncoding RNA to activate the hGH-N gene in the pituitary, but it is translated to a protein in the B cell [16, 39, 40] . In addition to these, our current data suggest that a DPE controls SMARCD2 and TCAM1P gene expression at this locus. Therefore, the SMARCD2-TCAM1P-hGH locus is a very important model to study multifunctional genomic elements and tissue-specific gene activation. [20] Chalmel F., Lardenois A., Evrard B., Mathieu R., Feig C., Demougin P., Gattiker A., Schulze W., Jégou B., Kirchhoff C. and Primig M. (2012) Global human tissue profiling and protein network analysis reveals distinct levels of transcriptional germline-specificity and identifies target genes for male infertility. Hum. Reprod. 27, 3233-3248.
[21] Chalmel F., Rolland A.D., Niederhauser-Wiederkehr C., Chung S.S.W., Demougin P., Gattiker from six independent experiments. n = 6. **P < 0.01 relative to linearized TCAM1P-Pro-luc construct, one-way ANOVA followed by Tukey-Kramer's test. 
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